Article Details
Retrieved on: 2022-09-20 18:02:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Advanced insights from CytoReason's disease models will support Pfizer's drug development process. September 20, 2022 08:00 ET | Source: CytoReason ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here